Complete Hemodynamic Profiling With Pulmonary Artery Catheters in Cardiogenic Shock Is Associated With Lower In-Hospital Mortality
- PMID: 33121702
- DOI: 10.1016/j.jchf.2020.08.012
Complete Hemodynamic Profiling With Pulmonary Artery Catheters in Cardiogenic Shock Is Associated With Lower In-Hospital Mortality
Abstract
Objectives: The purpose of this study was to investigate the association between obtaining hemodynamic data from early pulmonary artery catheter (PAC) placement and outcomes in cardiogenic shock (CS).
Background: Although PACs are used to guide CS management decisions, evidence supporting their optimal use in CS is lacking.
Methods: The Cardiogenic Shock Working Group (CSWG) collected retrospective data in CS patients from 8 tertiary care institutions from 2016 to 2019. Patients were divided by Society for Cardiovascular Angiography and Interventions (SCAI) stages and outcomes analyzed by the PAC-use group (no PAC data, incomplete PAC data, complete PAC data) prior to initiating mechanical circulatory support (MCS).
Results: Of 1,414 patients with CS analyzed, 1,025 (72.5%) were male, and 494 (34.9%) presented with myocardial infarction; 758 (53.6%) were in SCAI Stage D shock, and 263 (18.6%) were in Stage C shock. Temporary MCS devices were used in 1,190 (84%) of those in advanced CS stages. PAC data were not obtained in 216 patients (18%) prior to MCS, whereas 598 patients (42%) had complete hemodynamic data. Mortality differed significantly between PAC-use groups within the overall cohort (p < 0.001), and each SCAI Stage subcohort (Stage C: p = 0.03; Stage D: p = 0.05; Stage E: p = 0.02). The complete PAC assessment group had the lowest in-hospital mortality than the other groups across all SCAI stages. Having no PAC assessment was associated with higher in-hospital mortality than complete PAC assessment in the overall cohort (adjusted odds ratio: 1.57; 95% confidence interval: 1.06 to 2.33).
Conclusions: The CSWG is a large multicenter registry representing real-world patients with CS in the contemporary MCS era. Use of complete PAC-derived hemodynamic data prior to MCS initiation is associated with improved survival from CS.
Keywords: cardiogenic shock; hemodynamics; mechanical circulatory support; pulmonary artery catheter.
Copyright © 2020 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.
Conflict of interest statement
Author Relationship With Industry Funding was received from the Cardiogenic Shock Working Group Fund, Abbott, Abiomed, and Boston Scientific. The Cardiogenic Shock Working Group had full control over the content of the manuscript and none of the industry sponsors had a role in the final presentation of this work. Dr. Garan has served as an unpaid advisor to Abiomed; and received research support from Abbott. Dr. Kanwar is an advisor to Abiomed. Dr. Mahr is a consultant for Abbott, Medtronic, and Abiomed. Dr. O’Neill is a consultant for Abiomed and Abbott. Dr. Kapur has received speaker/consulting honoraria from Abbott, Abiomed, Boston Scientific, Medtronic, MDStart, LivaNova, Getinge; and has received Institutional Research Grants from Abbott, Abiomed, Boston Scientific and MDStart.
Comment in
-
Can a Pulmonary Artery Catheter Improve Outcomes in Cardiogenic Shock?JACC Heart Fail. 2020 Nov;8(11):914-916. doi: 10.1016/j.jchf.2020.08.013. JACC Heart Fail. 2020. PMID: 33121703 No abstract available.
-
Pulmonary Artery Catheter in Cardiogenic Shock: Will the Benefits Finally Outweigh the Costs and Complications?JACC Heart Fail. 2021 Apr;9(4):322-323. doi: 10.1016/j.jchf.2020.12.007. JACC Heart Fail. 2021. PMID: 33795123 No abstract available.
-
Reply: Pulmonary Artery Catheter in Cardiogenic Shock: Will the Benefits Finally Outweigh the Costs and Complications?JACC Heart Fail. 2021 Apr;9(4):323-324. doi: 10.1016/j.jchf.2020.12.008. JACC Heart Fail. 2021. PMID: 33795125 No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical